share_log

HC Wainwright & Co. Reiterates Buy on Ekso Bionics Holdings, Maintains $9 Price Target

Benzinga ·  Apr 28, 2023 06:17

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Ekso Bionics Holdings (NASDAQ:EKSO) with a Buy and maintains $9 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment